Anti-infective agents useful against multidrug-resistant strains of bacteria
    1.
    发明授权
    Anti-infective agents useful against multidrug-resistant strains of bacteria 有权
    对多药耐药菌株有效的抗感染剂

    公开(公告)号:US06946446B2

    公开(公告)日:2005-09-20

    申请号:US09791408

    申请日:2001-02-23

    CPC分类号: C07H17/08 A61K31/335

    摘要: The invention relates to novel methods for using macrolide anti-infective agents. The macrolide anti-infective agents demonstrate antibacterial activity against multi-drug resistant strains of bacteria and, in particular, methicillin-resistant Staphylococcus aureus (MRSA). Methods for inhibiting the activity of multi-drug resistant bacterial organisms and methods for treating a bacterial infection caused by such organisms are described herein.

    摘要翻译: 本发明涉及使用大环内酯类抗感染剂的新方法。 大环内酯类抗感染剂表现出抗多药耐药菌株,特别是耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌活性。 本文描述了抑制多药耐药性细菌生物体的活性的方法和用于治疗由此类生物引起的细菌感染的方法。

    C-2 modified erythromycin derivatives
    2.
    发明授权
    C-2 modified erythromycin derivatives 有权
    C-2修饰红霉素衍生物

    公开(公告)号:US06355620B1

    公开(公告)日:2002-03-12

    申请号:US09312517

    申请日:1999-05-14

    IPC分类号: A61K3170

    CPC分类号: C07H17/08

    摘要: A compound having the formula selected from the group consisting of a compound of formula I a compound of formula II a compound of formula III as well as and pharmaceutically acceptable salts, esters, solvates, metabolites, and prodrugs thereof, are useful in treating bacterial infections. Also provided are pharmaceutically acceptible compositions, methods of treating bacterial infections, and processes for the preparation of the compounds.

    摘要翻译: 具有下式的化合物选自式Ia化合物式IIa化合物式III化合物及其药学上可接受的盐,酯,溶剂合物,代谢物和前药,可用于治疗细菌感染。 还提供了药学上可接受的组合物,治疗细菌感染的方法和化合物的制备方法。

    6-O-carbamate ketolide derivatives
    3.
    发明授权
    6-O-carbamate ketolide derivatives 有权
    6-O-氨基甲酸酯酮内酯衍生物

    公开(公告)号:US06420535B1

    公开(公告)日:2002-07-16

    申请号:US09577645

    申请日:2000-05-24

    IPC分类号: C07H1708

    CPC分类号: C07H17/08 C40B40/00

    摘要: The invention relates to a novel 6-O-carbamate ketolide compound or a pharmaceutically acceptable salt, ester, solvate or prodrug thereof, to a composition comprising the compound and a suitable carrier, a method of preparing the compound, and a method of treatment and prevention of infections in a mammal.

    摘要翻译: 本发明涉及一种新的6-O-氨基甲酸酯酮内酯化合物或其药学上可接受的盐,酯,溶剂合物或前药,其包含该化合物和合适的载体的组合物,该化合物的制备方法和 预防哺乳动物感染。

    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having
antibacterial activity
    4.
    发明授权
    3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity 有权
    具有抗菌活性的3-N改性的6-O-取代的红霉素酮内酯衍生物

    公开(公告)号:US06034069A

    公开(公告)日:2000-03-07

    申请号:US132256

    申请日:1998-08-11

    IPC分类号: C07H17/08 A61K31/70 C07H1/00

    CPC分类号: C07H17/08

    摘要: Novel 3'-N-modified 6-O-substituted erythromycin ketolide compounds and pharmaceutically acceptable salts and esters thereof having antibacterial activity having a formula ##STR1## compositions comprising a therapeutically effective amount of a compound of the invention in combination with a pharmaceutically acceptable carrier, as well as a method for treating bacterial infections by administering to a mammal a pharmaceutical composition containing a therapeutically-effective amount of a compound of the invention.

    摘要翻译: 具有抗细菌活性的新颖的3'-N-修饰的6-O-取代的红霉素酮内酯化合物及其药学上可接受的盐和酯,其具有包含治疗有效量的本发明化合物与药学上可接受的载体的组成的式 作为通过向哺乳动物施用含有治疗有效量的本发明化合物的药物组合物来治疗细菌感染的方法。

    9a-azalides with antibacterial activity
    9.
    发明授权
    9a-azalides with antibacterial activity 有权
    具有抗菌活性的9a-azalides

    公开(公告)号:US06764996B1

    公开(公告)日:2004-07-20

    申请号:US09624849

    申请日:2000-07-25

    IPC分类号: C07D41312

    CPC分类号: C07D413/14 C07D413/12

    摘要: Compounds of formula (I) formula (II) formula (III) and formula (IV) or pharmaceutically acceptable salts or prodrugs thereof, are antibacterial agents. Compositions containing the compounds, processes for making the compounds, synthetic intermediates employed in the processes, and methods for treatment and prevention of bacterial infections are disclosed.

    摘要翻译: 式(I)式(II)式(III)和式(IV)的化合物或其药学上可接受的盐或前药是抗菌剂。 公开了含有化合物的组合物,制备该化合物的方法,该方法中使用的合成中间体以及用于治疗和预防细菌感染的方法。